by Daniel Shvartsman European markets traded higher Tuesday as general market bullishness - or complacency appears to have set in for investors. At 12:50 CET (1150 GMT) the DAX...
Investing.com – U.S. stocks were lower after the close on Friday, as losses in the Oil & Gas, Financials and Industrials sectors led shares lower. At the close in NYSE, the Dow...
Investing.com – France stocks were higher after the close on Thursday, as gains in the Foods & Drugs, Gas & Water and General Financial sectors led shares higher. At the close in...
As of late, it has definitely been a great time to be an investor in Genfit SA (NASDAQ:GNFT) . The stock has moved higher by 2.2% in the past month, while it is also above its 20...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) gained 3.02% after the company posted mixed results for the first quarter. The company reported a wider-than-expected loss but beat...
For Immediate ReleaseChicago, IL – May 1, 2019 - Stocks in this week’s article Teledyne Technologies Inc. (NYSE:TDY) , Genfit SA (NASDAQ:GNFT) , Shoe Carnival...
Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The Company targets a number of therapeutic areas, which includes nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), NASH diagnosis, NASH-induced fibrosis and IL-17 dependent autoimmune diseases. The Company’s research programs develop diversified pipeline of drug candidates, including Elafibranor in NASH, which is in phase III; Elafibranor in PBC, which is in phase II; In-Vitro diagnostic test for NASH and Nitazoxanide in fibrosis, which is still in clinical stage, among others.
| Average | 8.93 (+109.70% Upside) |
| High | 13.00 |
| Low | 5.00 |
| Price | 4.26 |
| No. of Analysts | 6 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 151.73 | 153.10 | 150.78 | -2.77 | -1.79% | 67.99M | NASDAQ | |||
| 256.77 | 258.30 | 254.78 | -1.58 | -0.61% | 22.43M | NASDAQ | |||
| 71.58 | 73.85 | 71.40 | -3.66 | -4.86% | 13.08M | NASDAQ | |||
| 28.69 | 29.65 | 28.61 | -1.26 | -4.22% | 48.56M | NASDAQ | |||
| 5.86 | 7.03 | 3.11 | +2.81 | +92.13% | 242.10M | NASDAQ | |||
| 102.18 | 103.95 | 100.65 | -1.21 | -1.17% | 80.80M | NASDAQ | |||
| 102.90 | 104.36 | 101.88 | -1.88 | -1.79% | 31.61M | NASDAQ | |||
| 194.76 | 198.17 | 189.92 | +4.78 | +2.52% | 185.21M | NASDAQ | |||
| 13.14 | 13.21 | 12.78 | -0.09 | -0.68% | 75.13M | NYSE | |||
| 27.89 | 28.09 | 27.08 | +0.41 | +1.49% | 21.03M | NYSE | |||
| 105.45 | 106.28 | 103.22 | -0.88 | -0.83% | 14.96M | NYSE | |||
| 0.8407 | 0.8789 | 0.83 | -0.0038 | -0.45% | 275.65K | NASDAQ | |||
| 361.48 | 368.45 | 360.68 | -4.42 | -1.21% | 4.98M | NASDAQ | |||
| 1.56 | 1.60 | 1.18 | +0.360 | +30.00% | 32.60M | NYSE | |||
| 132.93 | 134.88 | 131.86 | -2.09 | -1.55% | 6.83M | NASDAQ |